|
US6267958B1
(en)
*
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
IL130061A
(en)
*
|
1996-11-27 |
2001-09-13 |
Genentech Inc |
Affinity purification of polypeptide on protein a matrix
|
|
BRPI9910332B8
(pt)
*
|
1998-05-06 |
2021-05-25 |
Genentech Inc |
método para purificação de um polipeptídio a partir de uma composição
|
|
US6949245B1
(en)
*
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
US20030086924A1
(en)
*
|
1999-06-25 |
2003-05-08 |
Genentech, Inc. |
Treatment with anti-ErbB2 antibodies
|
|
WO2001083781A2
(en)
*
|
2000-04-28 |
2001-11-08 |
Millennium Pharmaceuticals, Inc. |
14094, a novel human trypsin family member and uses thereof
|
|
US20020119148A1
(en)
|
2000-09-01 |
2002-08-29 |
Gerritsen Mary E. |
ErbB4 antagonists
|
|
ES2321539T3
(es)
*
|
2001-06-05 |
2009-06-08 |
Genetics Institute, Llc |
Procedimientos relativos a la purificacion de proteinas altamente anionicas.
|
|
AU2002351353A1
(en)
*
|
2001-12-19 |
2003-09-02 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
|
DE60231651D1
(de)
*
|
2001-12-21 |
2009-04-30 |
Immunex Corp |
Proteinreinigungsverfahren
|
|
ATE417858T1
(de)
*
|
2002-02-05 |
2009-01-15 |
Genentech Inc |
Proteinaufreinigung
|
|
AU2003262087B2
(en)
|
2002-09-11 |
2010-11-11 |
Chugai Seiyaku Kabushiki Kaisha |
Protein purification method
|
|
HUE033623T2
(en)
|
2002-09-11 |
2017-12-28 |
Genentech Inc |
protein purification
|
|
KR101412271B1
(ko)
*
|
2003-05-09 |
2014-06-25 |
듀크 유니버시티 |
Ｃｄ２０-특이적 항체 및 이를 이용한 방법
|
|
HUE050171T2
(hu)
|
2003-07-28 |
2020-11-30 |
Genentech Inc |
Protein-A kioldódásának csökkentése protein-A affinitáskromatográfia során
|
|
US20050065136A1
(en)
*
|
2003-08-13 |
2005-03-24 |
Roby Russell R. |
Methods and compositions for the treatment of infertility using dilute hormone solutions
|
|
EP3192872A1
(en)
|
2003-08-26 |
2017-07-19 |
The Regents of the University of Colorado, a body corporate |
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
|
|
WO2005037869A2
(en)
*
|
2003-10-15 |
2005-04-28 |
Applera Corporation |
Method of reducing leachate from protein a affinity media
|
|
WO2005045058A2
(en)
*
|
2003-10-27 |
2005-05-19 |
Monogram Biosciences, Inc. |
Detecting human anti-therapeutic antibodies
|
|
RS58420B1
(sr)
|
2003-11-05 |
2019-04-30 |
Roche Glycart Ag |
Cd20 antitela sa povećanim afinitetom za vezivanje fc receptora i efektornom funkcijom
|
|
US20050239757A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Roby Russell R |
Hormone treatment of macular degeneration
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
ZA200706017B
(en)
|
2005-01-21 |
2008-12-31 |
Genentech Inc |
Fixed dosing of her antibodies
|
|
JP2008530123A
(ja)
*
|
2005-02-09 |
2008-08-07 |
ジェネンテック・インコーポレーテッド |
マトリックスメタロプロテアーゼアンタゴニストを用いたｈｅｒ２のシェディングの阻害
|
|
EP1850874B1
(en)
|
2005-02-23 |
2013-10-16 |
Genentech, Inc. |
Extending time to disease progression or survival in ovarian cancer patients using pertuzumab
|
|
US7754861B2
(en)
*
|
2005-03-23 |
2010-07-13 |
Bio-Rad Laboratories, Inc. |
Method for purifying proteins
|
|
US20090247421A1
(en)
*
|
2005-03-23 |
2009-10-01 |
Egisto Boschetti |
Diverse chemical libraries bound to small particles with paramagnetic properties
|
|
JP2006316040A
(ja)
|
2005-05-13 |
2006-11-24 |
Genentech Inc |
Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法
|
|
PE20070207A1
(es)
*
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
CA2628116A1
(en)
*
|
2005-10-31 |
2007-12-13 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
ES2439641T3
(es)
|
2005-12-20 |
2014-01-24 |
Bristol-Myers Squibb Company |
Composiciones y procedimientos de producción de una composición
|
|
AR058568A1
(es)
|
2005-12-20 |
2008-02-13 |
Bristol Myers Squibb Co |
Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
|
|
AU2007204987B2
(en)
*
|
2006-01-06 |
2011-11-24 |
Amgen Inc. |
Methods and systems for isolating target molecules from complex solutions by column-chromatography using eluants containing organic solvents
|
|
US8263750B2
(en)
*
|
2006-03-16 |
2012-09-11 |
Amgen Inc. |
Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
|
|
FR2902799B1
(fr)
|
2006-06-27 |
2012-10-26 |
Millipore Corp |
Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
|
|
TW200821026A
(en)
*
|
2006-09-08 |
2008-05-16 |
Wyeth Corp |
Arginine wash in protein purification using affinity chromatography
|
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
TW201516149A
(zh)
|
2006-09-13 |
2015-05-01 |
Abbvie Inc |
細胞培養改良
|
|
JP5448825B2
(ja)
*
|
2006-10-19 |
2014-03-19 |
ヤンセン バイオテツク，インコーポレーテツド |
非凝集抗体Ｆｃドメインの製造方法
|
|
US8362217B2
(en)
*
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8569464B2
(en)
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US20100267933A1
(en)
|
2006-12-21 |
2010-10-21 |
Moya Wilson |
Purification of proteins
|
|
AU2008209404B2
(en)
*
|
2007-01-22 |
2012-08-16 |
Genentech, Inc. |
Polyelectrolyte precipitation and purification of antibodies
|
|
ES2366593T3
(es)
*
|
2007-01-26 |
2011-10-21 |
Merck Serono S.A. |
Purificación de proteínas de fusión taci-fc empleando la tecnología de cuerpos grasos.
|
|
MX2009008981A
(es)
*
|
2007-03-02 |
2009-09-02 |
Genentech Inc |
Prediccion de respuesta a un inhibidor her.
|
|
US9551033B2
(en)
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
|
ES2417148T3
(es)
|
2007-06-08 |
2013-08-06 |
Genentech, Inc. |
Marcadores de expresión génica de la resistencia tumoral al tratamiento con inhibidor de HER2
|
|
LT3597659T
(lt)
*
|
2007-07-09 |
2023-05-10 |
Genentech, Inc. |
Disulfidinės jungties redukcijos prevencijos būdas gaminant polipeptidą rekombinantiniu būdu
|
|
SG175597A1
(en)
|
2007-10-30 |
2011-11-28 |
Genentech Inc |
Antibody purification by cation exchange chromatography
|
|
TWI472339B
(zh)
|
2008-01-30 |
2015-02-11 |
Genentech Inc |
包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
|
|
US8999702B2
(en)
*
|
2008-06-11 |
2015-04-07 |
Emd Millipore Corporation |
Stirred tank bioreactor
|
|
BRPI0812682A2
(pt)
|
2008-06-16 |
2010-06-22 |
Genentech Inc |
tratamento de cáncer de mama metastático
|
|
AR073295A1
(es)
|
2008-09-16 |
2010-10-28 |
Genentech Inc |
Metodos para tratar la esclerosis multiple progresiva. articulo de fabricacion.
|
|
WO2010037041A2
(en)
|
2008-09-26 |
2010-04-01 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
CN104974251A
(zh)
|
2008-10-20 |
2015-10-14 |
Abbvie公司 |
在抗体纯化过程中的病毒灭活
|
|
JP5808249B2
(ja)
*
|
2008-10-20 |
2015-11-10 |
アッヴィ・インコーポレイテッド |
プロテインａアフィニティークロマトグラフィーを用いる抗体の単離および精製
|
|
DK2370561T3
(da)
*
|
2008-12-16 |
2019-10-21 |
Emd Millipore Corp |
Omrøringstankreaktor og fremgangsmåde
|
|
US8846878B1
(en)
*
|
2009-01-23 |
2014-09-30 |
Cubrc Corporation |
Method and device for isolating a protein sample
|
|
TWI461211B
(zh)
|
2009-03-20 |
2014-11-21 |
Genentech Inc |
抗－ｈｅｒ抗體
|
|
EP2435071A1
(en)
|
2009-05-29 |
2012-04-04 |
F. Hoffmann-La Roche AG |
Modulators for her2 signaling in her2 expressing patients with gastric cancer
|
|
CN102471377B
(zh)
*
|
2009-07-24 |
2015-04-22 |
霍夫曼-拉罗奇有限公司 |
优化抗体的生产
|
|
AR078161A1
(es)
*
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
|
MX342442B
(es)
|
2009-10-01 |
2016-09-29 |
F Hoffmann-La Roche Ag * |
Filtracion final en multiples pasos.
|
|
WO2011038894A1
(en)
|
2009-10-01 |
2011-04-07 |
F. Hoffmann-La Roche Ag |
Protein a chromatography
|
|
PL2499165T3
(pl)
|
2009-11-13 |
2017-04-28 |
Grifols Therapeutics Inc. |
Preparaty zawierające czynnik von willenbranda (vwf) oraz sposoby, zestawy i zastosowania z nim powiązane
|
|
WO2011073389A1
(en)
|
2009-12-18 |
2011-06-23 |
Novartis Ag |
Wash solution and method for affinity chromatography
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
EP2536748B1
(en)
|
2010-02-18 |
2014-08-20 |
Genentech, Inc. |
Neuregulin antagonists and use thereof in treating cancer
|
|
CA2794674A1
(en)
|
2010-04-01 |
2011-10-06 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
EP3597671B1
(en)
|
2010-05-17 |
2022-09-21 |
EMD Millipore Corporation |
Stimulus responsive polymers for the purification of biomolecules
|
|
WO2011146568A1
(en)
|
2010-05-19 |
2011-11-24 |
Genentech, Inc. |
Predicting response to a her inhibitor
|
|
GB201012603D0
(en)
|
2010-07-27 |
2010-09-08 |
Ucb Pharma Sa |
Protein purification
|
|
EP2643353A1
(en)
|
2010-11-24 |
2013-10-02 |
Novartis AG |
Multispecific molecules
|
|
SG191186A1
(en)
|
2010-12-15 |
2013-07-31 |
Baxter Int |
Eluate collection using conductivity gradient
|
|
WO2012085111A1
(en)
|
2010-12-23 |
2012-06-28 |
F. Hoffmann-La Roche Ag |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
|
EP2702077A2
(en)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
US9938353B2
(en)
|
2011-06-24 |
2018-04-10 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
JP2014526891A
(ja)
|
2011-08-17 |
2014-10-09 |
ジェネンテック， インコーポレイテッド |
ニューレグリン抗体とその使用
|
|
DK2766040T3
(da)
|
2011-10-14 |
2019-07-22 |
Hoffmann La Roche |
Pertuzumab, trastuzumab, docetaxel og carboplatin til behandling af brystkræft i et tidligt stadie
|
|
US9327023B2
(en)
|
2011-10-25 |
2016-05-03 |
The Regents Of The University Of Michigan |
HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells
|
|
CA2854330A1
(en)
*
|
2011-11-02 |
2013-05-10 |
Genentech, Inc. |
Overload and elute chromatography
|
|
RU2019103083A
(ru)
|
2011-11-30 |
2019-03-22 |
Дженентек, Инк. |
МУТАЦИИ ErbB3 ПРИ РАКЕ
|
|
WO2013083810A1
(en)
|
2011-12-09 |
2013-06-13 |
F. Hoffmann-La Roche Ag |
Identification of non-responders to her2 inhibitors
|
|
CA2896951A1
(en)
|
2012-01-10 |
2013-07-18 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
US20130259867A1
(en)
|
2012-03-27 |
2013-10-03 |
Genentech, Inc. |
Diagnosis and treatments relating to her3 inhibitors
|
|
EP2647709B1
(en)
*
|
2012-04-05 |
2016-02-24 |
F. Hoffmann-La Roche AG |
Amine compounds for the selective preparation of biological samples
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
|
WO2013177118A2
(en)
*
|
2012-05-21 |
2013-11-28 |
Abbvie Inc. |
Novel purification of non-human antibodies using protein a affinity chromatography
|
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
AU2013309506A1
(en)
|
2012-09-02 |
2015-03-12 |
Abbvie Inc. |
Methods to control protein heterogeneity
|
|
KR102196230B1
(ko)
|
2012-09-17 |
2020-12-29 |
더블유.알. 그레이스 앤드 캄파니-콘. |
크로마토그래피 매질 및 장치
|
|
CN104768536B
(zh)
|
2012-09-17 |
2019-03-29 |
格雷斯公司 |
官能化微粒状载体材料和其制备和使用方法
|
|
WO2014066328A1
(en)
|
2012-10-23 |
2014-05-01 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
|
CA2889298C
(en)
|
2012-11-30 |
2024-01-02 |
Anton Belousov |
Identification of patients in need of pd-l1 inhibitor cotherapy
|
|
JP2016510411A
(ja)
|
2013-02-04 |
2016-04-07 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Ｗｎｔ経路インヒビターによる処置の方法およびモニタリング
|
|
WO2014137903A2
(en)
|
2013-03-08 |
2014-09-12 |
Genzyme Corporation |
Integrated continuous manufacturing of therapeutic protein drug substances
|
|
AU2013381687A1
(en)
|
2013-03-12 |
2015-09-24 |
Abbvie Inc. |
Human antibodies that bind human TNF-alpha and methods of preparing the same
|
|
WO2014151878A2
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
|
|
US8921526B2
(en)
|
2013-03-14 |
2014-12-30 |
Abbvie, Inc. |
Mutated anti-TNFα antibodies and methods of their use
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
BR112015024926A2
(pt)
|
2013-04-16 |
2017-10-10 |
Genentech Inc |
composições, artigo de fabricação, métodos para tratar um paciente com câncer, para avaliar uma composição, para avaliar a atividade biológica, para produzir uma composição e para avaliar a fragmentação de uma composição e variante de pertuzumabe
|
|
WO2014192877A1
(ja)
*
|
2013-05-29 |
2014-12-04 |
Jsr株式会社 |
洗浄用組成物、タンパク質精製方法、及びタンパク質
|
|
KR101847004B1
(ko)
*
|
2013-07-12 |
2018-04-10 |
메르크 파텐트 게엠베하 |
표적 단백질을 함유하는 샘플로부터 단편들의 활성탄을 이용한 제거
|
|
KR102332302B1
(ko)
|
2013-09-13 |
2021-12-01 |
제넨테크, 인크. |
세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법
|
|
EP3683232A1
(en)
|
2013-09-13 |
2020-07-22 |
F. Hoffmann-La Roche AG |
Methods and compositions comprising purified recombinant polypeptides
|
|
EP3052640A2
(en)
|
2013-10-04 |
2016-08-10 |
AbbVie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
WO2015073884A2
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
CN105407905B
(zh)
|
2014-01-03 |
2020-03-03 |
生物辐射实验室股份有限公司 |
蛋白a洗脱产物中杂质的去除
|
|
EP3094390B1
(en)
|
2014-01-16 |
2021-07-07 |
W.R. Grace & CO. - CONN. |
Affinity chromatography media and chromatography devices
|
|
TWI709569B
(zh)
|
2014-01-17 |
2020-11-11 |
美商健臻公司 |
無菌層析樹脂及其用於製造方法的用途
|
|
TWI709570B
(zh)
|
2014-01-17 |
2020-11-11 |
美商健臻公司 |
無菌層析法及製法
|
|
SG10201809411PA
(en)
|
2014-04-25 |
2018-11-29 |
Genentech Inc |
Methods of treating early breast cancer with trastuzumab-mcc-dm1 and pertuzumab
|
|
CN107847907A
(zh)
|
2014-05-02 |
2018-03-27 |
格雷斯公司 |
官能化载体材料以及制备和使用官能化载体材料的方法
|
|
US11566082B2
(en)
|
2014-11-17 |
2023-01-31 |
Cytiva Bioprocess R&D Ab |
Mutated immunoglobulin-binding polypeptides
|
|
CN107614015A
(zh)
|
2015-05-30 |
2018-01-19 |
豪夫迈·罗氏有限公司 |
治疗her2阳性局部晚期或先前未治疗的转移性乳腺癌的方法
|
|
KR102566292B1
(ko)
|
2015-06-05 |
2023-08-10 |
더블유.알. 그레이스 앤드 캄파니-콘. |
흡착성 바이오프로세싱 정화제와 이의 제조 및 사용 방법
|
|
WO2017087280A1
(en)
|
2015-11-16 |
2017-05-26 |
Genentech, Inc. |
Methods of treating her2-positive cancer
|
|
WO2017194554A1
(en)
|
2016-05-10 |
2017-11-16 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Combinations therapies for the treatment of cancer
|
|
US10730908B2
(en)
|
2016-05-11 |
2020-08-04 |
Ge Healthcare Bioprocess R&D Ab |
Separation method
|
|
WO2017194592A1
(en)
|
2016-05-11 |
2017-11-16 |
Ge Healthcare Bioprocess R&D Ab |
Method of storing a separation matrix
|
|
US10654887B2
(en)
|
2016-05-11 |
2020-05-19 |
Ge Healthcare Bio-Process R&D Ab |
Separation matrix
|
|
US10703774B2
(en)
|
2016-09-30 |
2020-07-07 |
Ge Healthcare Bioprocess R&D Ab |
Separation method
|
|
US10889615B2
(en)
|
2016-05-11 |
2021-01-12 |
Cytiva Bioprocess R&D Ab |
Mutated immunoglobulin-binding polypeptides
|
|
US11753438B2
(en)
|
2016-05-11 |
2023-09-12 |
Cytiva Bioprocess R&D Ab |
Method of cleaning and/or sanitizing a separation matrix
|
|
US10513537B2
(en)
|
2016-05-11 |
2019-12-24 |
Ge Healthcare Bioprocess R&D Ab |
Separation matrix
|
|
WO2018045587A1
(zh)
*
|
2016-09-12 |
2018-03-15 |
广东东阳光药业有限公司 |
一种抗vegf类单克隆抗体的纯化方法
|
|
KR20190075114A
(ko)
|
2016-11-04 |
2019-06-28 |
제넨테크, 인크. |
Her2-양성 유방암의 치료
|
|
EP3562844A1
(en)
|
2016-12-28 |
2019-11-06 |
Genentech, Inc. |
Treatment of advanced her2 expressing cancer
|
|
EP3570884B1
(en)
|
2017-01-17 |
2020-09-30 |
Genentech, Inc. |
Subcutaneous her2 antibody formulations
|
|
WO2018160654A2
(en)
|
2017-03-02 |
2018-09-07 |
Genentech, Inc. |
Adjuvant treatment of her2-positive breast cancer
|
|
EP3615695A1
(en)
|
2017-04-24 |
2020-03-04 |
Genentech, Inc. |
Erbb2/her2 mutations in the transmebrane or juxtamembrane domain
|
|
CA3067735A1
(en)
|
2017-08-17 |
2019-02-21 |
Just Biotherapeutics, Inc. |
Method of purifying glycosylated protein from host cell galectins and other contaminants
|
|
KR20210049155A
(ko)
|
2018-08-31 |
2021-05-04 |
젠자임 코포레이션 |
멸균 크로마토그래피 수지 및 제조 공정에서 이의 용도
|
|
AU2020253470A1
(en)
|
2019-04-02 |
2021-11-04 |
Bondwell Technologies Lp |
Functionalized Ubx protein materials for enhanced purification of antibodies
|